Pharmaceutical & healthcare product manufacturer
Sarbanes-Oxley Act (SOX) compliance audit review
Undisclosed
Grant Thornton team
Manufacturing
Internal controls

We are delighted to have supported an international pharmaceutical and healthcare product manufacturer headquartered in France

 

Our Business Risk team was engaged to perform Sarbanes-Oxley Act (SOX) compliance audit review for the Singapore operations:

  • Evaluated and tested the adequacy and effectiveness of internal controls against SOX requirements for various processes over IT General Controls
  • Provided an overall evaluation of the review and conducted discussions on the evaluation result with local management and key stakeholders

 

Value added

The Business Risk assessed the risks and current state of controls by highlighting the issues and gaps identified through the design and operating effectiveness testing. They provided the client with recommendations for consideration, taking into account the size and nature of the business as well as industry best practices in key focus areas (for example, Change Control Management, User Access Management, and Cyber).

In addition, the team's ongoing discussions with key stakeholders allowed them to better understand the business, allowing for more pragmatic recommendations to mitigate the identified issues and gaps.